相关实验视频
Updated: Jan 15, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.1K
一个患有唐氏综合征的53岁老人慢性复发性异常性心周溢血:一个病例报告
Rossana Izzo1, Eugenia Morello1, Simone Sarzilla2
1Ente Ospedaliero Cantonale, Ospedale San Giovanni Bellinzona Switzerland.
Clinical case reports
|October 13, 2025
概括
患有唐氏综合征的患者面临心周溢血的风险更高. 这一案例突出了心电图 (ECG) 作为一种关键的诊断工具,用于在唐氏综合征患者中管理这种情况.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 心周溢出是一种严重的疾病,具有多种不同的病因.
- 患有唐氏综合征的个体对心周溢血的敏感性较高.
- 早期诊断和管理对于有利的患者结果至关重要.
研究的目的:
- 在患有唐氏综合征的患者中呈现一种异常心周溢血病例.
- 强调心电图 (ECG) 在这种特定患者群体中的诊断意义.
- 为了强调及时干预唐氏综合征中心周溢血的重要性.
主要方法:
- 病例报告详细介绍了一个患有唐氏综合征和心周溢血的患者.
- 对临床表现,诊断结果和管理策略的审查.
- 专注于心电图 (ECG) 在诊断中的作用.
主要成果:
- 患有唐氏综合征的患者被诊断出异常心周溢血.
- 心电图 (ECG) 提供了关键的诊断信息.
- 基于心电图发现的迅速管理导致了有效的治疗.
结论:
- 患有唐氏综合征的患者可以发生异常心周溢出.
- 电心电图 (ECG) 是诊断心周溢血的宝贵工具.
- 及时的心电图解释有助于有效的管理和改善预后.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Cardiomyopathy IV: Restrictive Cardiomyopathy
453
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
453
Pericarditis II: Clinical Features and Diagnostic Tests
285
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
285
Pericarditis III: Medical Management
307
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
307
Rheumatic Heart Disease I: Introduction
433
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
433
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468

